Efficacy and safety of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment: results of the phase 2 dare study
Terpos, E., Symeonidis, A., Delimpasi, S., Zamagni, E., Katodritou, E., Rivolti, E., Kyrtsonis, M., Fotiou, D., Kanellias, N., Migkou, M., Roussou, M., Gavriatopoulou, M., Hatjiharissi, E., Cavo, M.,Volume:
42
Journal:
Hematology, Transfusion and Cell Therapy
DOI:
10.1016/j.htct.2020.09.043
Date:
October, 2020
File:
PDF, 356 KB
2020